Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor
about
The role of epoxyeicosatrienoic acids in the cardiovascular systemSoluble epoxide hydrolase: gene structure, expression and deletionStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerAberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis modelSoluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7Genetic deletion of soluble epoxide hydrolase attenuates inflammation and fibrosis in experimental obstructive nephropathy.Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction.Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft.11,12-Epoxyecosatrienoic acids mitigate endothelial dysfunction associated with estrogen loss and aging: Role of membrane depolarization.Novel therapies for hemodialysis vascular access dysfunction: myth or reality?The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury.Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
P2860
Q28256560-C88CA865-3840-4DD2-B68C-34D7E45DC173Q28291292-B5A16025-0B5F-4B33-AC56-6D4A5569716BQ28304230-218E7BB0-86CD-4F84-85BC-BF4D9142B146Q28397805-06CC9B42-061D-4B1B-AA32-2D52E6496A08Q34774458-93A0DD86-2C17-48CF-BE42-9DB0936899F1Q35061561-17B63E6E-820B-4972-972A-15A8D1406FDCQ35742804-0AFBF61C-6A58-421A-B045-D5A6379546F3Q35770697-708B850F-7552-430B-9892-E7057A38D32DQ37150118-52E07F83-5539-496A-90F5-D8D484E2A2ABQ37359091-6BE8E626-1895-4035-928B-8141829A90E7Q39644067-05E562C9-1389-44F8-9834-51B521BD067FQ47158221-112EA383-D0A6-4161-8C1C-A51EEC6E865BQ47779172-449DAD61-81FF-4AFF-B0DB-1CD8DD7D6D32Q49972956-3502B4A2-C05B-44C6-987E-13B9A5451915
P2860
Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@ast
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@en
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@nl
type
label
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@ast
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@en
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@nl
prefLabel
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@ast
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@en
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@nl
P2093
P2860
P1476
Soluble epoxide hydrolase expr ...... le epoxide hydrolase inhibitor
@en
P2093
Alfred K Cheung
Christi M Terry
William G Sanders
P2860
P304
P356
10.1152/AJPCELL.00386.2011
P407
P577
2012-08-01T00:00:00Z